RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.930
-0.210 (-4.09%)
At close: Sep 22, 2026, 4:00 PM EDT
5.03
+0.10 (2.03%)
Pre-market: Sep 23, 2026, 7:11 AM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $205.05 million as of September 22, 2026. Its market cap has decreased by -46.74% in one year.
Market Cap
205.05M
Enterprise Value
6.84M
1-Year Change
-46.74%
Ranking
Category
Stock Price
$4.93
ChartMarket Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $205.05M, a decrease of -51.68%. That is a compound annual growth rate of -13.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 205.05M | -52.14% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Treace Medical Concepts | 298.51M |
| Standard BioTools | 294.36M |
| InfuSystem Holdings | 261.11M |
| Electromed | 230.66M |
| Neuronetics | 221.73M |
| Profound Medical | 214.25M |
| Quantum-Si incorporated | 171.76M |
| Lucid Diagnostics | 170.44M |